RUA Life Sciences posts narrower first-half pre-tax loss
30th Jun 2026 12:30
(Sharecast News) - RUA Life Sciences narrowed its first-half post-tax loss to £203,000 from £635,000, it reported on Tuesday, as revenue rose 6.1% to £2.75m and adjusted EBITDA swung to a £76,000 profit from a £227,000 loss.
Read moreRUA Life Sciences flags smaller EBITDA loss
22nd May 2026 14:04
(Sharecast News) - RUA Life Sciences said in an update on Friday that it expected to report a smaller EBITDA loss, broadly reaching breakeven on an adjusted basis, after revenue growth in its UK contract development and manufacturing and biomaterials businesses offset weaker trading at Abiss.
Read moreRUA Life Sciences reports improvement in earnings, cash burn
30th Jan 2026 11:55
(Sharecast News) - RUA Life Sciences reported a sharp improvement in earnings and cash burn for the 18 months ended 30 September on Friday, after doubling revenues and strengthening its contract development and manufacturing business through an acquisition.
Read moreRUA Life Sciences posts sharp increase in revenue
4th Nov 2025 16:15
(Sharecast News) - RUA Life Sciences reported a sharp increase in revenue for the 18 months ended 30 September on Tuesday, reflecting its successful transition from a research-led organisation to a revenue-generating medical device group.
Read moreRUA Life Sciences posts sharp increase in revenue
4th Nov 2025 16:15
(Sharecast News) - RUA Life Sciences reported a sharp increase in revenue for the 18 months ended 30 September on Tuesday, reflecting its successful transition from a research-led organisation to a revenue-generating medical device group.
Read moreRUA Life Sciences inks new supply agreement
29th Jan 2025 10:23
(Sharecast News) - Medical device business RUA Life Sciences said on Wednesday that it has inked a new supply agreement with an initial value of more than £500,000.
Read moreRUA Life Sciences acquires French implantable devices business
9th Sep 2024 10:42
(Sharecast News) - Medical devices business RUA Life Sciences has acquired implantable devices manufacturer Analytic Biosurgical Solutions for €80,000 in cash from the French liquidator of IPSA SAS, the former parent company of Abiss.
Read moreRUA Life Sciences reports strong start to financial year
27th Aug 2024 12:33
(Sharecast News) - RUA Life Sciences, a medical device company specialising in implantable textiles and biostable polymers, reported a strong start to its financial year on Tuesday, with trading in the first four months exceeding management expectations.
Read moreRUA Life Sciences makes progress with heart valve leaflet composite
20th Dec 2023 12:46
(Sharecast News) - RUA Life Sciences updated the market on its progress with the RUA leaflet composite on Wednesday.
Read moreRUA Life Sciences revenue, profits fall in first half
18th Dec 2023 13:44
(Sharecast News) - Biostable polymer medical device specialist RUA Life Sciences reported a gross profit of £0.62m in its first half on Monday, with a margin of 77%, representing a decrease from £0.88m and 79% year-on-year.
Read moreRUA Life Sciences confident despite first-half weakness
24th Nov 2023 13:57
(Sharecast News) - Medical device specialist RUA Life Sciences said in a trading update on Friday that it expected revenue for the year to meet forecasts despite some order disruption.
Read moreRUA Life Sciences shares jump on strategy update
20th Nov 2023 14:39
(Sharecast News) - Shares in RUA Life Sciences rocketed on Monday after the company updated the market on its strategy, focusing on its medical device businesses.
Read moreRUA narrows losses after strong first-half sales
14th Nov 2022 17:02
(Sharecast News) - Medical device group RUA Life Sciences said in an update on Monday that trading in the first half had been "strong", with revenue ahead of expectations.
Read moreRUA Life Sciences tumbles as losses look set to widen
27th May 2022 10:41
(Sharecast News) - RUA Life Sciences reported increased sales growth in a full-year trading update on Friday, amid recovery from Covid-19 disruption and advances in its business processes and management to minimise the risk of a further delay to the regulatory approval of RUA Vascular's graft range.
Read moreRUA Vascular submits premarket notification to US FDA
3rd Nov 2021 14:47
(Sharecast News) - Medical devices company RUA Life Sciences said on Wednesday that RUA Vascular has submitted a premarket notification, or '510k', the US Food and Drug Administration (FDA), for a range of polymerically-sealed vascular grafts.
Read more